Home / Pipeline / Albaconazole 100mg + Albaconazole 200mg + Albaconazole 400mg + Albaconazole 400mg + Placebo 400 mg Products Albaconazole 100mg + Albaconazole 200mg + Albaconazole 400mg + Albaconazole 400mg + Placebo 400 mg
Albaconazole 100mg + Albaconazole 200mg + Albaconazole 400mg + Albaconazole 400mg + Placebo 400 mg Phase 2 Completed 💤 Quiet Interest: 35/100
Jul 16, 2008 → Feb 19, 2010
About Albaconazole 100mg + Albaconazole 200mg + Albaconazole 400mg + Albaconazole 400mg + Placebo 400 mg Albaconazole 100mg + Albaconazole 200mg + Albaconazole 400mg + Albaconazole 400mg + Placebo 400 mg is a phase 2 stage product being developed by GSK plc for Onychomycosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00730405. Target conditions include Onychomycosis.
What happened to similar drugs? 2 of 10 similar drugs in Onychomycosis were approved
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT00730405 Phase 2 Completed Jul 16, 2008 Feb 19, 2010 Onychomycosis
Product Company Stage Hype Score NVXT Solution + Vehicle of test product Sun Pharmaceutical Phase 2 NVXT topical + Placebo (Vehicle) Topical Sun Pharmaceutical Phase 2 SCH 56592 + SCH 56592 + SCH 56592 + SCH 56592 + Terbinafine + Placebo Merck Phase 2 terbinafine + Placebo + terbinafine + Placebo Novartis Phase 3 terbinafine hydrogen chloride + amorolfine nail lacquer Novartis Phase 3 terbinafine + Placebo + terbinafine + Placebo Novartis Phase 3 AN2690 Pfizer Phase 2 AN2690, 2.5% + AN2690, 5% + AN2690, 7.5% + Vehicle Pfizer Phase 2 AN2690 Solution, 5.0% + AN2690 Solution, 7.5% Pfizer Phase 2 AN2690 Topical Solution, 5% + Solution Vehicle Pfizer Phase 3 AN2690 + AN2690 Pfizer Phase 2 Tavaborole 5% Topical Solution Pfizer Approved AN2690 Solution, 5.0% Pfizer Phase 2 AN2690, 2.5% + AN2690, 5% + AN2690, 7.5% + AN2690 Solution Vehicle Pfizer Phase 2 AN2690 Pfizer Phase 2 AN2690 Topical Solution, 5% + Solution Vehicle Pfizer Phase 3 AN2690 + AN2690 + AN2690 Pfizer Phase 1 Albaconozole + Placebo + Albaconozole + Placebo + Albaconozole + Placebo GSK plc Phase 1 Itraconazole 100mg capsules + Itraconazole 200mg tablets + Placebo tablets GSK plc Phase 3 Albaconazole tablet 400mg + Albaconazole 100mg capsules, then albaconazole 400mg tablet GSK plc Phase 1